Chronic hepatitis B cases may exceed 2 million, higher in U.S. than thought

Check in with us as we feature the latest trends, research and news in medicine, health and science. A team of Star Tribune staffers will aggregate updates from news wires, websites, magazines and medical journals.

resize text
subscribe via RSS

Chronic hepatitis B cases may exceed 2 million, higher in U.S. than thought

Posted by: Colleen Stoxen Updated: May 31, 2012 - 11:18 AM

0
comments
print

Tweet
share

email
Email share

your name

your email

recipients email

+ add a comment add a comment

The prevalence of chronic hepatitis B virus (HBV) infection in the U.S. may be as high as 2.2 million cases according to a new study in Hepatology journal. Findings suggest the higher prevalence can be attributed to foreign-born persons who were infected in their country of origin prior to arrival in the U.S. Emigrants from Asia and Africa, where infection with hepatitis B is highly endemic, represent close to 70% of the 1.32 million foreign-born persons living with chronic HBV in the U.S. in 2009.

Chronic HBV is a major health burden that experts say affects up to 400 million individuals worldwide, with up to 25% at risk of premature mortality due to primary liver cancer and end-stage liver disease if the infection is left untreated. In the U.S., the Centers for Disease Control and Prevention (CDC) estimate that in 2006 there were 800,000 to 1.4 million persons living with chronic HBV. However, previous reports may underestimate the true burden of chronic hepatitis B as individuals in the U.S. who are institutionalized, homeless, and foreign-born "at risk" populations are underrepresented on national health surveys.

"There is a wide discrepancy in the current estimates of the chronic HBV burden in the U.S.," explains lead author Dr. Kris Kowdley, Director of the Liver Center of Excellence at Virginia Mason Medical Center in Seattle, Washington. "Understanding the ethnic and cultural populations affected by chronic hepatitis B will provide more accurate estimates and help to develop programs for prevention, earlier diagnosis, and access to care for those at greatest risk."